SterRx recalls NOREPINEPHRINE 16 mg per 250mL injection (Rx only) due to lack of sterility assurance. This may cause infections if used improperly.
Lack of Assurance of Sterility
SterRx is recalling a specific 16 mg per 250 mL injection product because it lacks sterility assurance. This could lead to infections if the product is used without proper sterilization.
The product lacks sterility assurance, meaning it may contain harmful bacteria or other contaminants. If used without proper sterilization, this could lead to infections in patients.
Healthcare professionals who use this injection for medical treatments are affected. Patients receiving this medication under a doctor's supervision are at risk.
Check for the product name 'NOREPINEPHRINE, 16 mg per 250 mL, (64 mcg per mL) in 5% Dextrose Injection' with NDC 70324-002-01. This product was distributed by SterRx, LLC in Plattsburgh, NY.
Verify the product name and NDC code to confirm if it matches the recalled item.
The recall states there is a lack of sterility assurance, so it is not safe to use without proper sterilization.
The recall record does not specify a remedy or replacement process.
The recall record does not provide specific instructions for affected users.
We’ve drafted a message you can send SterRx to request your refund or repair — edit it as you like.
Subject: Recall D-0319-2022 — SterRx SterRx Hello, I own a SterRx that is covered by recall D-0319-2022 from SterRx. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
